Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature

J Infect Chemother. 2022 Dec;28(12):1658-1662. doi: 10.1016/j.jiac.2022.08.003. Epub 2022 Aug 10.

Abstract

Invasive mucormycosis is a refractory fungal infection. Central nervous system (CNS) mucormycosis is a rare complication caused by infiltration from the paranasal sinuses or hematogenous dissemination. Here, we present a case of a brain abscess, due to mucormycosis, diagnosed using burr craniotomy. A 25-year-old Japanese woman with relapsed-refractory acute lymphoblastic leukemia underwent cord blood transplantation (CBT). The patient experienced prolonged and profound neutropenia, and oral voriconazole was administered as primary antifungal prophylaxis. The patient received a conditioning regimen on day -11 and complained of aphasia and right hemiparesis on day -6. Magnetic resonance imaging (MRI) revealed a T2-weighted high-intensity area in the left frontal cortex. A brain abscess was suspected, and liposomal amphotericin B (L-AMB) administration was started. The patient underwent CBT as scheduled and underwent neutrophil engraftment on day 14. Although the patient achieved complete remission on day 28, her consciousness level gradually deteriorated. MRI revealed an enlarged brain lesion with a midline shift sign, suggesting brain herniation. Craniotomy was performed to relieve intracranial pressure and drain the abscess on day 38, and a diagnosis of cerebral mucormycosis was confirmed. The L-AMB dose was increased to 10 mg/kg on day 43. Although the patient's consciousness level improved, she died of hemorrhagic cystitis and aspiration pneumonia. Cerebral mucormycosis should be suspected if neurological symptoms are observed in stem cell transplant recipients. Prompt commencement of antifungal therapy and debridement are crucial because mucormycosis has a poor prognosis.

Keywords: Acute lymphoblastic leukemia; Cerebral mucormycosis; Cord blood transplantation.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Amphotericin B
  • Antifungal Agents / therapeutic use
  • Brain Abscess* / drug therapy
  • Central Nervous System
  • Female
  • Hematologic Neoplasms* / drug therapy
  • Humans
  • Mucormycosis* / complications
  • Mucormycosis* / diagnosis
  • Mucormycosis* / drug therapy
  • Voriconazole / therapeutic use

Substances

  • Antifungal Agents
  • liposomal amphotericin B
  • Amphotericin B
  • Voriconazole